About Phylos Bioscience
Phylos Bioscience is a private company based in Portland, Oregon. It has reported $23,895,766 raised in 11 offerings on Form D since February 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 19, 2025 | $583,418target not set | 8 | $72,927 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 15, 2024 | Nov 1, 2024 | $1,805,037of $4.0M target | 8 | $225K | EquityRule 506(b) | Form D ↗ |
| Nov 1, 2023 | Nov 7, 2023 | $150,000target not set | 1 | $150K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 10, 2023 | Feb 17, 2023 | $250,000of $1.0M target | 1 | $250K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Dec 10, 2021 | $0target not set | 0 | — | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 29, 2021 | May 5, 2021 | $2,500,000of $5.0M target | 4 | $625K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 29, 2020 | Jan 30, 2020amended Jan 23, 2025 | $4,518,519target not set | 25 | $180K | Equity, Securities on exerciseRule 506(b) | Form D/A ↗5 earlier filings |
| Apr 8, 2019 | Jan 3, 2019amended Apr 19, 2021 | $12,158,792of $26.0M target | 33 | $368K | Equity, Options, Securities on exerciseRule 506(c) | Form D/A ↗3 earlier filings |
| Dec 12, 2017 | Dec 26, 2017 | $250,000of $10.0M target | 1 | $250K | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 31, 2015 | Sep 17, 2015amended Sep 16, 2016 | $1,430,000of $5.5M target | 7 | $204K | Equity, Debt, OptionsRule 506(b) | Form D/A ↗2 earlier filings |
| Jan 20, 2015 | Feb 3, 2015 | $250,000of $2.0M target | 1 | $250K | EquityRule 506(b) | Form D ↗ |
| Total, 11 offerings | $23,895,766 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Phylos Bioscience's Form D filed Dec 19, 2025.
NK
BP
Barbara Peachey
Chief Financial Officer
RR
Ralph Risch
Executive officer and director
Also an executive officer, director and promoter at Conception Holdings.
TG
Timothy Gregory
Director
Also a director of phylos bioscience, inc., a promoter at Conception Holdings.
DP
David Patterson
Director
MM
Mina Mishrikey
Director
Earlier filings also listed Dylan Anderson (chief financial officer, last listed Dec 2021), Stephen Lile (executive officer, last listed Dec 2017), Mowgli Holmes (executive officer and director, last listed Dec 2017) and Dan Reiner (director, last listed Dec 2017).
Sources
- SECPhylos Bioscience, Inc. Form D/A, filed Jan 24, 2024
- SECPhylos Bioscience, Inc. Form D/A, filed Jan 26, 2023
- SECPhylos Bioscience, Inc. Form D/A, filed Jan 24, 2022
- SECPhylos Bioscience, Inc. Form D/A, filed Jan 27, 2021
- SECPhylos Bioscience, Inc. Form D/A, filed May 5, 2020
- SECPhylos Bioscience, Inc. Form D, filed Jan 30, 2020
- SECPhylos Bioscience, Inc. Form D/A, filed May 10, 2019
- SECPhylos Bioscience, Inc. Form D, filed Jan 3, 2019
- SECPhylos Bioscience, Inc. Form D/A, filed Sep 18, 2015
- SECPhylos Bioscience, Inc. Form D, filed Sep 17, 2015
- SECPhylos Bioscience, Inc. filing history